Department of Geriatric Medicine and Gerontology, Poznan University of Medical Sciences, Poznań, Poland.
Clin Interv Aging. 2020 Apr 22;15:567-574. doi: 10.2147/CIA.S245074. eCollection 2020.
Completion of the SARC-F questionnaire constitutes the obligatory first step in the diagnostic process of sarcopenia, according to the revised European consensus on the definition and diagnosis of sarcopenia published by the European Working Group on Sarcopenia in Older People2 (EWGSOP2). SARC-F has been recognized as the most up-to-date and coherent screening tool for sarcopenia. The aim of the study was to translate and to validate the Polish version of the SARC-F questionnaire.
The validation process was performed in two stages: 1) translation and intercultural adaptation and 2) clinical validation. The inclusion criteria were as follows: age ≥65 years, unimpaired mobility, and no cognitive impairment. The EWGSOP2 criteria were used to diagnose sarcopenia. Hand grip strength measurement, physical fitness test, and body weight composition analysis were conducted. Sensitivity, specificity, accuracy-likelihood ratios, and SARC-F predictive values were calculated using the EWGSOP2 criteria.
Sixty-seven people participated in the study of whom 21% were diagnosed with sarcopenia (SARC-F score: ≥4). The reliability of the questionnaire based on the Cronbach's alpha coefficient was 0.784. Sensitivity, specificity, and negative predictive values were 92.9%, 98.1%, and 98.1%, respectively.
The process of validating the SARC-F questionnaire against Polish conditions demonstrated its applicability as a simple and reliable tool for diagnosing sarcopenia in daily clinical practice with older adults.
根据欧洲老年人肌肉减少症工作组(EWGSOP2)发布的修订版欧洲肌少症定义和诊断共识,完成 SARC-F 问卷构成肌少症诊断过程的必要第一步。SARC-F 已被认为是最新和最连贯的肌少症筛查工具。本研究的目的是翻译和验证 SARC-F 问卷的波兰语版本。
验证过程分两个阶段进行:1)翻译和跨文化适应,2)临床验证。纳入标准为:年龄≥65 岁,活动能力不受影响,无认知障碍。使用 EWGSOP2 标准诊断肌少症。进行握力测量、体能测试和体重成分分析。使用 EWGSOP2 标准计算灵敏度、特异性、准确性似然比和 SARC-F 预测值。
共有 67 人参加了这项研究,其中 21%被诊断为肌少症(SARC-F 评分:≥4)。基于 Cronbach's alpha 系数的问卷可靠性为 0.784。灵敏度、特异性和阴性预测值分别为 92.9%、98.1%和 98.1%。
针对波兰情况验证 SARC-F 问卷的过程表明,它可以作为一种简单可靠的工具,用于在日常临床实践中诊断老年人的肌少症。